ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Boc-cis-4-Fmoc-Amino-L-proline
C25H28N2O6
452.5 g/mol
Pharmaceutical Intermediate

(4S)-4-N-Fmoc-amino-1-Boc-L-proline

CAS174148-03-9
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected amino acid derivative used as an intermediate in solid-phase peptide synthesis. Its structure incorporates orthogonal protecting groups compatible with standard Fmoc/t-Boc synthetic strategies.

Building block for peptide synthesisIntermediate in pharmaceutical manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (4S)-4-N-Fmoc-amino-1-Boc-L-proline?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Benzyl 3-bromo-4-oxopiperidine-1-carboxylate

CAS174184-13-5

pharmaceutical intermediate

ReferenceSame Category

2-amino-5-nitrobenzonitrile

CAS17420-30-3

pharmaceutical intermediate

ReferenceSame Category

1,4-Piperidinedicarboxylic-4-14C acid 1-(1,1-dimethylethyl) ester

CAS174316-71-3

pharmaceutical intermediate

ReferenceSame Category

Dichlorodivinylsilane

CAS1745-72-8

pharmaceutical intermediate

Referencesame scaffold

(9H-Fluoren-9-yl)methyl (S)-pyrrolidin-3-ylcarbamate

CAS1217635-77-2

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

InChIKey

UPXRTVAIJMUAQR-BTYIYWSLSA-N

SMILES

CC(C)(C)OC(=O)N1C[C@H](C[C@H]1C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Synonyms (14)
  • Fmoc-ABPC(2S,4S-OH

Sourcing (4S)-4-N-Fmoc-amino-1-Boc-L-proline?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→